Ecraprost

DB16148InvestigationalSmall molecule

Ecraprost is under investigation in clinical trial NCT00059657 (Efficacy/safety of Ecraprost in Lipid Emulsion for Treatment of Critical Leg Ischemia Due to Peripheral Arterial Disease).

Formula / weight: C₂₈H₄₈O₆ · 480.686 g/mol (avg)
Also known as: Circulase
Code names: AS-013

Resolves to

Compound

UNIIQ2XM6VR8DOCAS136892-64-3ChEMBLCHEMBL2104574

Structure

InChIKeyHITYEEHTEOQBAC-OSIGYOHNSA-NSMILESCCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(OC(=O)CCC)=C1CCCCCCC(=O)OCCCC

Targets

P34995PTGER1

What you can answer from here — as of April 23, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Ecraprost, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account